Navigation Links
NewCardio Announces Master Services Agreement With Dedicated Phase I
Date:8/5/2009

his agreement demonstrates the firm's commitment to the use of technology to improve quality and efficiency."

This Master Services Agreement is part of a transition from semi-automated methods to more advanced, higher quality, and more efficient methodologies made possible for the first time through the use of NewCardio's QTinno(TM) solution.

NewCardio's innovative 3D ECG platform technology dramatically improves the accuracy and significantly increases the diagnostic value of the standard 12-lead electrocardiogram (ECG). NewCardio's lead product is QTinno(TM), a software suite that provides an automated, comprehensive analysis of QT intervals and other ECG-based cardiac safety for the pharmaceutical industry and drug regulators. The Company believes that its QTinno(TM), software-based, analytical technology is the industry's first solution for the reliable automated analysis of ECGs used to determine cardiac toxicity during drug development.

About NewCardio, Inc.

NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology to provide higher accuracy to, and increase the value of, the standard 12-lead electrocardiogram (ECG). NewCardio's development-stage software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease (CVD), as well as cardiac safety assessment of drugs under development. NewCardio's three-dimensional ECG platform is designed to reduce the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. For more information, visit www.newcardio.com.

Forward-Looking Statements

This press rele
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NewCardio Leadership to Present Two Abstracts at ISCE Conference
2. Vincent W. Renz Joins NewCardio as President
3. NewCardio Announces Positive Results From Third Clinical Validation Study
4. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
5. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
6. Cryo-Cell Announces Celle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.
7. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
8. Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
9. Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
10. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
11. AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)...   InspireMD, Inc. (NYSE MKT: NSPR) ... protection systems ("EPS"), today announced that its MGuard ... MicroNet ™ has received the Frost & ... Award.  Through active market research efforts, Frost & ... the successful introduction of new and innovative products, ...
(Date:7/7/2015)... 2015   Bionik Laboratories Corp. (OTCBB: ... a core focus in robotic exoskeleton technology for ... announced today that it has completed an additional ... of its common stock and warrants for aggregate ... private placement transaction.  This equity financing is the ...
(Date:7/7/2015)... 2015  Essentialis, a venture-backed company focused on the development ... orphan neurobehavioral and metabolic diseases, today announced that Dr. ... corporate update at the Cantor Fitzgerald Inaugural Healthcare Conference. ... Wednesday, July 8, 2015 Time: 8:00 AM Eastern Time Location: ... Essentialis, Inc. Essentialis is a ...
Breaking Medicine Technology:InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3
... Quest Diagnostics Incorporated (NYSE: DGX ), the ... announced today the successful completion of its acquisition of ... means of a short-form merger under Delaware law, under ... merged with and into Celera, with Celera surviving the ...
... May 17, 2011 Amylin Pharmaceuticals, Inc. (Nasdaq: ... Tuesday, May 24, 2011 at 9:00 a.m. PT/12:00 p.m. ET ... the Annual Meeting, Daniel M. Bradbury, president and chief executive ... To access the webcast, please log on to the ...
Cached Medicine Technology:Quest Diagnostics Successfully Completes Acquisition of Celera 2
(Date:7/7/2015)... and Wellesley, MA (PRWEB) , ... July 07, ... ... National Institute of Whole Health (NIWH) have jointly announced a partnership focused ... addressing unsolved, chronic medical case studies. The study will be conducted with NIWH ...
(Date:7/7/2015)... ... July 07, 2015 , ... Nationally-renowned attorneys in the ... website, the Invokana Ketoacidosis Lawsuit Center . The website provides information on ... for persons wishing to learn more about Invokana lawsuits for kidney problems, ketoacidosis, ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... patient advocate, will be recognized by the White House as a “Champion of ... newly-launched President’s Precision Medicine Initiative, the Champions of Change program recognizes Gleason and ...
(Date:7/6/2015)... UK (PRWEB) , ... July 07, 2015 , ... ... in the in vitro universe. Increasing incidence of AIDS, advances in the molecular ... key growth driving forces. Recent advances in detection technologies and genetic engineering also ...
(Date:7/6/2015)... ... ... “ TapGlance ” was featured on NewsWatch as part of its monthly AppWatch, ... iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted ... visualize what rooms will look like before they even start renovating.. , Whether a ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 3Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2
... to give FDA needed regulatory authority,over tobacco products, ... a,statement by Ron Davis, M.D., American Medical Association ... of Representatives must take a critical step,to combat ... Control Act, and giving the FDA needed regulatory ...
... October 30, millions of breast,cancer survivors, advocates, friends, families ... to the Cure.", This "Raise Your Glasses" event ... memorialize those friends and family members,who we have lost, ... cause advocates, thanking supporters, and showing,conviction for the future ...
... stop drug-taking athletes from damaging sport by using performance ... challenge, according to a major four-decade review by three ... , Writing in the August issue of the ... that significant advances have been made in the fight ...
... in Oregon and Washington ... NASHVILLE, Tenn., July 29 HealthLeaders-InterStudy, a,leading ... Regence,BlueCross BlueShield of Oregon and Regence BlueShield of ... in the Medicare market.,According to the new report ...
... 29 American Imaging Management (AIM), an,operating subsidiary ... leading imaging,benefit management and technology company with health ... it has reached an,agreement to provide diagnostic imaging ... Vermont (BCBSVT)., "As a company that is ...
... a Difference, ROSEMONT, Ill., July 29 Organizers ... the $25,000,offer to Steve Bartman to sign one autograph ... says he should appear., The convention is scheduled ... E.,Stephens Convention Center in Rosemont, Ill., The Bartman ...
Cached Medicine News:Health News:Video: A 'Toast to the Cure' Set for October 30 Breast Cancer Survivors 'Raise Your Glasses' 2Health News:Scientists race to stay ahead of the drug-taking and genetic manipulation that threatens sport 2Health News:Scientists race to stay ahead of the drug-taking and genetic manipulation that threatens sport 3Health News:Regence Group's Oregon and Washington Blue Plans Are Well Positioned for Success in Local Medicare Market 2Health News:American Imaging Management Partners with Blue Cross and Blue Shield of Vermont 2Health News:Fans Encourage Steve Bartman to Accept $25,000 Autograph Offer 2
Facial Wrap...
Very compressive support for submental liposuction...
Ideal for autoplasty and liposuction of chin and cheeks...
Four way compression with simple contact closure...
Medicine Products: